UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Complete remission with romidepsin in a patient with T‐cell acute lymphoblastic leukemia refractory to induction hyper‐CVAD

Hematological oncology, 2018-02, Vol.36 (1), p.340-343

2018

Volltextzugriff (PDF)

Relationship of Reconstituted Adaptive and Innate Cytomegalovirus (CMV)-Specific Immune Responses with CMV Viremia in Hematopoietic Stem Cell Transplant Recipients

Clinical infectious diseases, 2009-12, Vol.49 (12), p.1777-1783

2009

Volltextzugriff (PDF)

A randomized, placebo-controlled trial of oral beclomethasone dipropionate as a prednisone-sparing therapy for gastrointestinal graft-versus-host disease

Blood, 2007-05, Vol.109 (10), p.4557-4563

2007

Volltextzugriff (PDF)

Amyloidosis relapsing after autologous stem cell transplantation treated with bortezomib: normalization of detectable serum-free light chains and reversal of tissue damage with improved suitability for transplant

Haematologica (Roma), 2010-03, Vol.95 (3), p.519-521

2010

Volltextzugriff (PDF)

Phase I Study of the Anti-CD22 Antibody-Drug Conjugate Pinatuzumab Vedotin with/without Rituximab in Patients with Relapsed/Refractory B-cell Non-Hodgkin Lymphoma

Clinical cancer research, 2017-03, Vol.23 (5), p.1167-1176

2017

Volltextzugriff (PDF)

Safety and efficacy of polatuzumab vedotin + obinutuzumab for relapsed/refractory non‐Hodgkin lymphomas: A phase IB/II study

American journal of hematology, 2022-01, Vol.97 (1), p.E24-E27

2022

Volltextzugriff (PDF)

A Phase III, Randomized, Double-blind, Placebo-controlled, Multinational Trial of Iseganan for the Prevention of Oral Mucositis in Patients Receiving Stomatotoxic Chemotherapy (PROMPT-CT Trial)

Leukemia & lymphoma, 2003-07, Vol.44 (7), p.1165-1172

2003

Volltextzugriff (PDF)

T Cell Priming Enhances IL-4 Gene Expression by Increasing Nuclear Factor of Activated T Cells

The Journal of immunology (1950), 1999-01, Vol.162 (2), p.860-870

1999

Volltextzugriff (PDF)

A phase I study of PRO131921, a novel anti-CD20 monoclonal antibody in patients with relapsed/refractory CD20 + indolent NHL: Correlation between clinical responses and AUC pharmacokinetics

Clinical immunology (Orlando, Fla.), 2014-09, Vol.154 (1), p.37-46

2014

Volltextzugriff (PDF)

The block to transcriptional elongation within the human c-myc gene is determined in the promoter-proximal region

Genes & development, 1992-11, Vol.6 (11), p.2201-2213

1992

Volltextzugriff (PDF)

Induction of alloantigen-specific hyporesponsiveness in human T lymphocytes by blocking interaction of CD28 with its natural ligand B7/BB1

The Journal of experimental medicine, 1993, Vol.177 (1), p.165-173

1993

Volltextzugriff (PDF)

In vivo footprinting of the human IL-2 gene reveals a nuclear factor bound to the transcription start site in T cells

Nucleic acids research, 1993-10, Vol.21 (20), p.4824-4829

1993

Volltextzugriff (PDF)

High-dose fractionated total-body irradiation, etoposide, and cyclophosphamide followed by autologous stem-cell support in patients with malignant lymphoma

Journal of clinical oncology, 1994-12, Vol.12 (12), p.2559-2566

1994

Volltextzugriff (PDF)

Pneumocystis carinii pneumonia associated with profound lymphopenia and abnormal T‐lymphocyte subset ratios during treatment for early‐stage breast carcinoma

Cancer, 1991-05, Vol.67 (9), p.2407-2409

1991

Volltextzugriff (PDF)

Chronic recurrent goodpasture's syndrome

The American journal of medicine, 1987-04, Vol.82 (4), p.833-835

1987

Volltextzugriff (PDF)

1 – 16 von 16

Suche als RSS-Feed

Aktive Filter

ThemaHumans

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(16)
Mit Volltextzugriff
(16)

Publikationsform

Artikel
(16)

Sprache

Englisch
(16)

Erscheinungsjahr

n.n

Thema

Life Sciences & Biomedicine
(13)
Science & Technology
(13)
Adult
(11)
Female
(9)
Male
(8)
Middle Aged
(8)
Biological And Medical Sciences
(7)
Hematology
(6)
Aged
(5)
Oncology
(5)
Treatment Outcome
(5)
Medical Sciences
(4)
Adolescent
(3)
Fundamental And Applied Biological Sciences. Psychology
(3)
Immunology
(3)
Lymphoma
(3)
Molecular Sequence Data
(3)
Placebos
(3)
Recurrence
(3)

14 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Complete remission with romidepsin in a patient with T‐cell acute lymphoblastic leukemia refractory to induction hyper‐CVAD

Relationship of Reconstituted Adaptive and Innate Cytomegalovirus (CMV)-Specific Immune Responses with CMV Viremia in Hematopoietic Stem Cell Transplant Recipients

A randomized, placebo-controlled trial of oral beclomethasone dipropionate as a prednisone-sparing therapy for gastrointestinal graft-versus-host disease

Amyloidosis relapsing after autologous stem cell transplantation treated with bortezomib: normalization of detectable serum-free light chains and reversal of tissue damage with improved suitability for transplant

A phase III, randomized, double-blind, placebo-controlled, study of iseganan for the reduction of stomatitis in patients receiving stomatotoxic chemotherapy

Phase I Study of the Anti-CD22 Antibody-Drug Conjugate Pinatuzumab Vedotin with/without Rituximab in Patients with Relapsed/Refractory B-cell Non-Hodgkin Lymphoma

Safety and efficacy of polatuzumab vedotin + obinutuzumab for relapsed/refractory non‐Hodgkin lymphomas: A phase IB/II study

A Phase III, Randomized, Double-blind, Placebo-controlled, Multinational Trial of Iseganan for the Prevention of Oral Mucositis in Patients Receiving Stomatotoxic Chemotherapy (PROMPT-CT Trial)

T Cell Priming Enhances IL-4 Gene Expression by Increasing Nuclear Factor of Activated T Cells

A phase I study of PRO131921, a novel anti-CD20 monoclonal antibody in patients with relapsed/refractory CD20 + indolent NHL: Correlation between clinical responses and AUC pharmacokinetics

The block to transcriptional elongation within the human c-myc gene is determined in the promoter-proximal region

Induction of alloantigen-specific hyporesponsiveness in human T lymphocytes by blocking interaction of CD28 with its natural ligand B7/BB1

In vivo footprinting of the human IL-2 gene reveals a nuclear factor bound to the transcription start site in T cells

High-dose fractionated total-body irradiation, etoposide, and cyclophosphamide followed by autologous stem-cell support in patients with malignant lymphoma

Pneumocystis carinii pneumonia associated with profound lymphopenia and abnormal T‐lymphocyte subset ratios during treatment for early‐stage breast carcinoma

Chronic recurrent goodpasture's syndrome

Aktive Filter

Suchergebnisse filtern